NCT00004079View on ClinicalTrials.gov

Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

September 30, 2005

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

SarCNU

Given PO

OTHER

pharmacological study

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00004079 - Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors | Biotech Hunter | Biotech Hunter